Contact Us

Developing Seattle Life Sciences

Seattle | Air Date: March 17 | 9:30 AM PDT

Speakers and Panels

Jon Gelb

Jon Gelb

Managing Director, Clarion Partners
Mark McCord-Amasis

Mark McCord-Amasis

Vice President, Real Estate & Facilities, Seattle Genetics
Uly Rivera

Uly Rivera

Life Science Lab Manager, Comotion Labs

Why This Matters

What You'll Learn:

  • How does the lack of square footage for growing biotech startups create more opportunities for Seattle life sciences development? 
  • Incubators are essential to anchoring tenants to a market. What are investors doing to further invest in expanding the South Lake Union area?  
  • New life science ground-up developments are costly and spec projects are unlikely. How does adaptive reuse create revenue opportunities for office, retail and hospitality assets? 
  • How are restrictive regulatory policies forcing life sciences outside of the urban core? What alternatives are being explored in secondary markets? 
  • What are lab tenants requiring from new spaces that Seattle has yet to provide? What are developers delivering in the Northeast that the PNW can incorporate at scale? 


How You'll Do More Business: You'll gain insight into leasing agreements gaining traction in the PNW, which tenants are wanting lab space, key strategies for finding potential in otherwise dead assets for lab conversions and what investors plan to pursue next. 


Who Attends: Engineers, architects, owners, developers, investors, government, contractors, lawyers, lenders.

Presented By


Interested in sponsoring a webinar? Contact